RICHTER Stock Overview
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Ft10,510.00 |
| 52 Week High | Ft11,260.00 |
| 52 Week Low | Ft8,550.00 |
| Beta | 0.34 |
| 1 Month Change | -1.50% |
| 3 Month Change | -2.41% |
| 1 Year Change | 18.89% |
| 3 Year Change | 22.14% |
| 5 Year Change | 62.95% |
| Change since IPO | 5,738.89% |
Recent News & Updates
Does Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Have A Healthy Balance Sheet?
Dec 05
Investors Holding Back On Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER)
Sep 17We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Can Stay On Top Of Its Debt
Aug 27Recent updates
Does Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Have A Healthy Balance Sheet?
Dec 05Investors Holding Back On Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER)
Sep 17We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Can Stay On Top Of Its Debt
Aug 27Earnings Report: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Missed Revenue Estimates By 9.3%
Aug 09Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Has A Pretty Healthy Balance Sheet
May 21Take Care Before Diving Into The Deep End On Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER)
Apr 26Analysts Have Made A Financial Statement On Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) Annual Report
Mar 05Is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) A Risky Investment?
Jan 20Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) Earnings Haven't Escaped The Attention Of Investors
Dec 27Shareholder Returns
| RICHTER | HU Pharmaceuticals | HU Market | |
|---|---|---|---|
| 7D | -2.2% | -1.0% | -2.0% |
| 1Y | 18.9% | 5.7% | 19.8% |
Return vs Industry: RICHTER exceeded the Hungarian Pharmaceuticals industry which returned 6.9% over the past year.
Return vs Market: RICHTER matched the Hungarian Market which returned 18.8% over the past year.
Price Volatility
| RICHTER volatility | |
|---|---|
| RICHTER Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in HU Market | 9.3% |
| 10% least volatile stocks in HU Market | 2.2% |
Stable Share Price: RICHTER has not had significant price volatility in the past 3 months compared to the Hungarian market.
Volatility Over Time: RICHTER's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1901 | 11,603 | Gabor Orban | www.gedeonrichter.com/hu-hu |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Fundamentals Summary
| RICHTER fundamental statistics | |
|---|---|
| Market cap | Ft1.91t |
| Earnings (TTM) | Ft211.64b |
| Revenue (TTM) | Ft839.60b |
9.0x
P/E Ratio2.3x
P/S RatioIs RICHTER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RICHTER income statement (TTM) | |
|---|---|
| Revenue | Ft839.60b |
| Cost of Revenue | Ft269.96b |
| Gross Profit | Ft569.64b |
| Other Expenses | Ft358.00b |
| Earnings | Ft211.64b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | 1.16k |
| Gross Margin | 67.85% |
| Net Profit Margin | 25.21% |
| Debt/Equity Ratio | 5.4% |
How did RICHTER perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield35%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 03:58 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Simon Mather | Barclays |
| Samuel England | Berenberg |
| Victoria Lambert | Berenberg |